Citations for
1COXPD14, FARS2
Clinical findings in a patient with FARS2 mutations and early-infantile-encephalopathy with epilepsy.
Raviglione F, Conte G, Ghezzi D, Parazzini C, Righini A, Vergaro R, Legati A, Spaccini L, Gasperini S, Garavaglia B, Mastrangelo M.
Am J Med Genet A 170(11):3004-3007. doi: 10.1002/ajmg.a.37836. Epub 2016 Aug 23. 2016
2COXPD14, FARS2
Mutations in FARS2 and non-fatal mitochondrial dysfunction in two siblings.
Vernon HJ, McClellan R, Batista DA, Naidu S.
Am J Med Genet A 167A(5):1147-51. doi: 10.1002/ajmg.a.36993. Epub 2015 Apr 6. 2015
3COXPD14, FARS2
Mutation of the human mitochondrial phenylalanine-tRNA synthetase causes infantile-onset epilepsy and cytochrome c oxidase deficiency.
Almalki A, Alston CL, Parker A, Simonic I, Mehta SG, He L, Reza M, Oliveira JM, Lightowlers RN, McFarland R, Taylor RW, Chrzanowska-Lightowlers ZM.
Biochim Biophys Acta 1842(1):56-64. doi: 10.1016/j.bbadis.2013.10.008. Epub 2013 Oct 24. 2014
4COXPD14, FARS2
Mitochondrial phenylalanyl-tRNA synthetase mutations underlie fatal infantile Alpers encephalopathy.
Elo JM, Yadavalli SS, Euro L, Isohanni P, Götz A, Carroll CJ, Valanne L, Alkuraya FS, Uusimaa J, Paetau A, Caruso EM, Pihko H, Ibba M, Tyynismaa H, Suomalainen A.
Hum Mol Genet 21(20):4521-9. Epub 2012 Jul 23. 2012